The latest special offer from BOTB could see you winning a supercar for an absolute pittance - but you need to be very quick ...

Amycretin, a novel once-weekly subcutaneous GLP-1 and amylin receptor agonist, was safe compared with other incretin-based ...

If your weight loss goals have taken a backward step, this simple device might be all you need to get back on track and shed ...

A new rule being implemented for the 2024 tax year means revenue over $5,000 collected through platforms like PayPal or Venmo ...

In 2023, the American Academy of Pediatrics published a clinical practice guideline recommending weight-loss medications, including glucagon-like peptide-1 (GLP-1) receptor agonists, as a supplement ...

Winfrey opened up about her decision to use a medication to help her lose weight in an interview with People. Her new TV ...

With the regular-season dual meet season beginning to wrap up, the lehighvalleylive individual wrestling rankings hope to ...

Found, a telehealth startup that treats obesity with medication and lifestyle coaching, unveiled new research showing tens of ...

Metsera, which is developing weight-loss drugs, said on Monday it is seeking a valuation of up to $1.78 billion in its U.S.

NPA chairman Nick Kaye told the PA news agency that while obesity is "one of the biggest challenges facing" the UK, they are ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...